↓ Skip to main content

Rho-Associated Kinase Inhibitors: Evolving Strategies in Glaucoma Treatment

Overview of attention for article published in Drugs, May 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
2 news outlets
twitter
3 X users

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
38 Mendeley
Title
Rho-Associated Kinase Inhibitors: Evolving Strategies in Glaucoma Treatment
Published in
Drugs, May 2019
DOI 10.1007/s40265-019-01130-z
Pubmed ID
Authors

Emily M. Schehlein, Alan L. Robin

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 38 100%

Demographic breakdown

Readers by professional status Count As %
Other 5 13%
Student > Doctoral Student 4 11%
Student > Bachelor 3 8%
Student > Ph. D. Student 3 8%
Student > Postgraduate 2 5%
Other 4 11%
Unknown 17 45%
Readers by discipline Count As %
Medicine and Dentistry 9 24%
Pharmacology, Toxicology and Pharmaceutical Science 3 8%
Nursing and Health Professions 2 5%
Agricultural and Biological Sciences 2 5%
Biochemistry, Genetics and Molecular Biology 1 3%
Other 3 8%
Unknown 18 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 September 2023.
All research outputs
#1,907,273
of 24,451,065 outputs
Outputs from Drugs
#175
of 3,406 outputs
Outputs of similar age
#41,187
of 354,942 outputs
Outputs of similar age from Drugs
#3
of 37 outputs
Altmetric has tracked 24,451,065 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,406 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 354,942 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.